Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer

Published:2015-08 Issue:4 Volume:15 Page:259-265
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Cancello Giuseppe,Bagnardi Vincenzo,Sangalli Claudia,Montagna Emilia,Dellapasqua Silvia,Sporchia Andrea,Iorfida Monica,Viale Giuseppe,Barberis Massimo,Veronesi Paolo,Luini Alberto,Intra Mattia,Goldhirsch Aron,Colleoni Marco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2003

2. Neoadjuvant chemotherapy in breast cancer: significant enhanced response with docetaxel;Smith;J Clin Oncol,2002

3. Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group;Von Minckwitz;J Clin Oncol,2005

4. Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer:a randomized pilot trial of the Hoosier Oncology Group;Miller;J Clin Oncol,1999

5. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment;Colleoni;Clin Cancer Res,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ginsenoside CK combined with cisplatin on the proliferation and migration of human cervical cancer HeLa cells via Ras/ERK/MAPK pathway;Journal of Functional Foods;2023-03

2. Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer;International Journal of Nanomedicine;2022-09

3. Pathological complete response following cisplatin or carboplatin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: A systematic review and meta‑analysis;Experimental and Therapeutic Medicine;2021-11-26

4. Evaluation of solid tumor response to sequential treatment cycles via a new computational hybrid approach;Scientific Reports;2021-11-02

5. Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer;Pharmaceutics;2021-09-16